$17.00
0.09% today
NYSE, Aug 25, 05:47 pm CET
ISIN
US58502B1061
Symbol
MD

MEDNAX, Inc. Stock price

$17.01
+4.27 33.52% 1M
+1.33 8.48% 6M
+3.89 29.65% YTD
+5.99 54.36% 1Y
-2.44 12.55% 3Y
-1.80 9.57% 5Y
-60.69 78.11% 10Y
-1.60 8.60% 20Y
NYSE, Closing price Fri, Aug 22 2025
+0.86 5.33%

Key metrics

Basic
Market capitalization
$1.5b
Enterprise Value
$1.7b
Net debt
$259.2m
Cash
$348.3m
Shares outstanding
86.9m
Valuation (TTM | estimate)
P/E
13.1 | 9.2
P/S
0.8 | 0.8
EV/Sales
0.9 | 0.9
EV/FCF
7.7
P/B
1.8
Financial Health
Equity Ratio
35.5%
Return on Equity
-13.0%
ROCE
12.1%
ROIC
9.8%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$1.9b | $1.9b
EBITDA
$236.7m | $239.5m
EBIT
$213.0m | $209.5m
Net Income
$109.9m | $160.9m
Free Cash Flow
$227.0m
Growth (TTM | estimate)
Revenue
-3.1% | -3.6%
EBITDA
24.7% | 10.9%
EBIT
39.7% | 14.1%
Net Income
143.6% | 262.4%
Free Cash Flow
126.0%
Margin (TTM | estimate)
Gross
-
EBITDA
12.2% | 12.4%
EBIT
11.0%
Net
5.7% | 8.3%
Free Cash Flow
11.7%
More
EPS
$1.3
FCF per Share
$2.6
Short interest
3.0%
Employees
4k
Rev per Employee
$490.0k
Show more

Is MEDNAX, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

MEDNAX, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a MEDNAX, Inc. forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a MEDNAX, Inc. forecast:

Buy
63%
Hold
38%

Financial data from MEDNAX, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,941 1,941
3% 3%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 1,610 1,610
4% 4%
83%
- Research and Development Expense - -
-
-
237 237
25% 25%
12%
- Depreciation and Amortization 24 24
36% 36%
1%
EBIT (Operating Income) EBIT 213 213
40% 40%
11%
Net Profit 110 110
144% 144%
6%

In millions USD.

Don't miss a Thing! We will send you all news about MEDNAX, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MEDNAX, Inc. Stock News

Neutral
Business Wire
7 days ago
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Announces $250 Million Share Repurchase Program.
Positive
The Motley Fool
20 days ago
Pediatrix Medical Group (MD 5.04%), a leader in neonatal and maternal-fetal healthcare services, reported its second-quarter 2025 earnings on August 5, 2025. The company delivered a standout quarter, with non-GAAP earnings per share (EPS) of $0.53, beating analyst expectations of $0.42 by 25.9% (non-GAAP).
Neutral
Seeking Alpha
20 days ago
Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Kasandra H. Rossi - Executive VP, Treasurer & CFO Mark S.
More MEDNAX, Inc. News

Company Profile

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Head office United States
CEO Mark Ordan
Employees 4,120
Founded 1979
Website www.pediatrix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today